AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30903329 — intervention group
Group type: COMPARATOR
Intervention: Regimen A vs Regimen C
Number of subjects: 60
Study 30903329 — intervention group
Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 60
Study 28659201 — intervention group
Group type: EXPERIMENTAL
Intervention: Embrace intervention (care and support from an elderly-care team including a specialist in Gerontology, a district nurse, and a social worker)
Number of subjects: 1456
Study 28659201 — intervention group
Group type: COMPARATOR
Intervention: Control arm (standard care)
Number of subjects: 1456
Study 28659201 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers' report on implementation of integrated care
Number of subjects: 1456
Study 26162662 — intervention group
Group type: EXPERIMENTAL
Intervention: High and moderate baseline expectancies of success
Number of subjects: 118
Study 26162662 — intervention group
Group type: COMPARATOR
Intervention: Low baseline expectancies of success
Number of subjects: 118
Study 24473589 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 0
Study 24473589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21714641 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (CT) screening
Number of subjects: 53454
Study 21714641 — intervention group
Group type: COMPARATOR
Intervention: Single-view posteroanterior chest radiography
Number of subjects: 53454
Study 18657938 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention
Number of subjects: 198
Study 18657938 — intervention group
Group type: COMPARATOR
Intervention: Assessment control group
Number of subjects: 198
Study 17133893 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaning-centered psycho-educational group intervention
Number of subjects: 0
Study 17133893 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 15286133 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapies directed at correcting demineralization-remineralization imbalance
Number of subjects: 0
Study 15286133 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic technologies under development
Number of subjects: 0
Study 15286133 — intervention group
Group type: EXPERIMENTAL
Intervention: Outcome indices reflecting cavitation and lesion status
Number of subjects: 0
Study 11217014 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial sleep deprivation (delayed bedtime or early awakening)
Number of subjects: 8
Study 11217014 — intervention group
Group type: COMPARATOR
Intervention: Zolpidem-induced sleep (10 mg)
Number of subjects: 8
Study 11217014 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 8
Study 9273107 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly purified human folliculostimulin (FSH-HP)
Number of subjects: 0
Study 9273107 — intervention group
Group type: COMPARATOR
Intervention: Human menopausal gonadotrophin (hMG)
Number of subjects: 0
Study 8486328 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (SB) 250 mg
Number of subjects: 3000
Study 8486328 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (SB) 1,000 mg
Number of subjects: 3000
Study 8486328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000
Study 3813061 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% plain (Group 1)
Number of subjects: 60
Study 3813061 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% in 8% glucose (Group 2)
Number of subjects: 60
Study 3813061 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.5% in 8% glucose (Group 3)
Number of subjects: 60
Study 31601448 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartoon illustration
Number of subjects: 204
Study 31601448 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical drawing
Number of subjects: 204
Study 31601448 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography scan (CT)
Number of subjects: 204
Study 31601448 — intervention group
Group type: EXPERIMENTAL
Intervention: Illustrated leaflets (any style)
Number of subjects: 204
Study 31601448 — intervention group
Group type: COMPARATOR
Intervention: Control leaflet (no images)
Number of subjects: 204
Study 29638188 — intervention group
Group type: EXPERIMENTAL
Intervention: Production-learning condition
Number of subjects: 0
Study 29638188 — intervention group
Group type: COMPARATOR
Intervention: Comprehension-learning condition
Number of subjects: 0
Study 26511988 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 150
Study 26511988 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 150
Study 26511988 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine
Number of subjects: 150
Study 26511988 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 150
Study 24162462 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsified isoflurane (EI) at doses starting from 0.3 mg/kg to 64.6 mg/kg
Number of subjects: 78
Study 22305834 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 946
Study 22305834 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 946
Study 20299628 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (FP) 500 microg bid + active theophylline capsules (plasma level of 8.8-12.4 mg/L)
Number of subjects: 30
Study 20299628 — intervention group
Group type: COMPARATOR
Intervention: Inhaled fluticasone propionate (FP) alone
Number of subjects: 30
Study 20299628 — intervention group
Group type: COMPARATOR
Intervention: Placebo theophylline capsules + inhaled placebo
Number of subjects: 30
Study 20299628 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with FP and theophylline
Number of subjects: 30
Study 18577010 — intervention group
Group type: EXPERIMENTAL
Intervention: MSG substitutes
Number of subjects: 10
Study 18577010 — intervention group
Group type: COMPARATOR
Intervention: MSG
Number of subjects: 10
Study 16022206 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mail intervention promoting physical activity and nutrition (1 message per week for 12 weeks)
Number of subjects: 2121
Study 16022206 — intervention group
Group type: COMPARATOR
Intervention: Control group (no weekly messages)
Number of subjects: 2121
Study 12449309 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium sulfate as a graft/barrier
Number of subjects: 17
Study 12449309 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium sulfate plus doxycycline
Number of subjects: 17
Study 12449309 — intervention group
Group type: EXPERIMENTAL
Intervention: Demineralized freeze-dried bone allograft (DFDBA)
Number of subjects: 17
Study 10347528 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter valves
Number of subjects: 0
Study 10347528 — intervention group
Group type: COMPARATOR
Intervention: Conventional urinary drainage systems
Number of subjects: 0
Study 7856777 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-level, multi-channel, 4-year intervention
Number of subjects: 20047
Study 1961958 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2 mg/kg (n = 40)
Number of subjects: 80
Study 1961958 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone 5 mg/kg (n = 40)
Number of subjects: 80
Study 6789294 — intervention group
Group type: EXPERIMENTAL
Intervention: Alterations in PEEP (Positive End-Expiratory Pressure)
Number of subjects: 20
Study 6789294 — intervention group
Group type: EXPERIMENTAL
Intervention: Alterations in PIP (Peak Inspiratory Pressure)
Number of subjects: 20
Study 6789294 — intervention group
Group type: EXPERIMENTAL
Intervention: Alterations in inspiratory/expiratory ratio
Number of subjects: 20
Study 6789294 — intervention group
Group type: EXPERIMENTAL
Intervention: Increases in PEEP and decreases in PIP
Number of subjects: 20
Study 6789294 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreases in PEEP and increases in PIP
Number of subjects: 20
Study 6789294 — intervention group
Group type: EXPERIMENTAL
Intervention: Alterations in PIP
Number of subjects: 20
Study 30786162 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam IV 30 mg
Number of subjects: 0
Study 30786162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29125976 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 430
Study 26879101 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 100
Study 26879101 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 100
Study 24462012 — intervention group
Group type: EXPERIMENTAL
Intervention: Group medical clinics
Number of subjects: 239
Study 24462012 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 239
Study 23039801 — intervention group
Group type: EXPERIMENTAL
Intervention: CO₂
Number of subjects: 141
Study 23039801 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 141
Study 20302385 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (TM) referrals
Number of subjects: 800
Study 20302385 — intervention group
Group type: COMPARATOR
Intervention: Regular face-to-face hospital referrals
Number of subjects: 800
Study 17356966 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed reminders alone
Number of subjects: 10354
Study 17356966 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed reminders with physician prompts
Number of subjects: 10354
Study 17356966 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 10354
Study 16332659 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavone-enriched cereal bars (50 mg/d)
Number of subjects: 117
Study 16332659 — intervention group
Group type: COMPARATOR
Intervention: Placebo cereal bars
Number of subjects: 117
Study 16332659 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavone treatment
Number of subjects: 117
Study 12444863 — intervention group
Group type: EXPERIMENTAL
Intervention: PSV protocol (n = 62)
Number of subjects: 182
Study 12444863 — intervention group
Group type: EXPERIMENTAL
Intervention: VSV protocol (n = 60)
Number of subjects: 182
Study 12444863 — intervention group
Group type: COMPARATOR
Intervention: No protocol (n = 60)
Number of subjects: 182
Study 10980840 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct thrombin inhibitors (hirudin, hirulog) as adjuncts to thrombolytic therapy
Number of subjects: 0
Study 10980840 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0
Study 10980840 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirudin administered at a mean of 34 and 50 minutes after thrombolytic therapy
Number of subjects: 0
Study 10980840 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct thrombin inhibitors administered prior to thrombolysis
Number of subjects: 0
Study 7594905 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritodrine hydrochloride infusion
Number of subjects: 0
Study 7594905 — intervention group
Group type: COMPARATOR
Intervention: Non-treated control
Number of subjects: 0
Study 2183052 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with irradiation (27 Gy) of the involved field
Number of subjects: 129
Study 2183052 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 129
Study 6775956 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzbromarone
Number of subjects: 52
Study 6775956 — intervention group
Group type: EXPERIMENTAL
Intervention: Probenecid
Number of subjects: 52
Study 6775956 — intervention group
Group type: EXPERIMENTAL
Intervention: Probenecid in patients with renal insufficiency
Number of subjects: 52
Study 30270415 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 120
Study 30270415 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 120
Study 28339738 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering of TNF inhibitors (TNFi)
Number of subjects: 171
Study 28339738 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 171
Study 25588456 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa (100/25 mg of l-dopa/carbidopa daily)
Number of subjects: 10
Study 25588456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 24090447 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuotemporal cue
Number of subjects: 33
Study 24090447 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cue
Number of subjects: 33
Study 24090447 — intervention group
Group type: COMPARATOR
Intervention: Uncued condition
Number of subjects: 33
Study 21345996 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-SDM
Number of subjects: 123
Study 21345996 — intervention group
Group type: EXPERIMENTAL
Intervention: mETDRS
Number of subjects: 123
Study 21345996 — intervention group
Group type: COMPARATOR
Intervention: ND-SDM
Number of subjects: 123
Study 21345996 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 123
Study 19835117 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (Group A)
Number of subjects: 187
Study 19835117 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (Group B)
Number of subjects: 187
Study 19835117 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus acupoint injection (Group C)
Number of subjects: 187
Study 19835117 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture plus acupoint injection (Group D)
Number of subjects: 187
Study 17919229 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon and lamivudine combination therapy
Number of subjects: 0
Study 17919229 — intervention group
Group type: COMPARATOR
Intervention: Pegylated interferon monotherapy
Number of subjects: 0
Study 17919229 — intervention group
Group type: COMPARATOR
Intervention: Conventional interferon monotherapy
Number of subjects: 0
Study 17919229 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional interferon and lamivudine combination therapy
Number of subjects: 0
Study 15482039 — intervention group
Group type: EXPERIMENTAL
Intervention: 1st grade single- and multiple-rater screening models
Number of subjects: 396
Study 15482039 — intervention group
Group type: EXPERIMENTAL
Intervention: Early screening
Number of subjects: 396
Study 15635354 — intervention group
Group type: EXPERIMENTAL
Intervention: Juice reconstituted from frozen concentrate on day 1
Number of subjects: 0
Study 15635354 — intervention group
Group type: EXPERIMENTAL
Intervention: Juice reconstituted from frozen concentrate on day 8
Number of subjects: 0
Study 15635354 — intervention group
Group type: EXPERIMENTAL
Intervention: Chilled juice on day 1
Number of subjects: 0
Study 15635354 — intervention group
Group type: EXPERIMENTAL
Intervention: Chilled juice on day 8
Number of subjects: 0
Study 15635354 — intervention group
Group type: EXPERIMENTAL
Intervention: Juice from frozen concentrate on day 1
Number of subjects: 0
Study 15635354 — intervention group
Group type: EXPERIMENTAL
Intervention: Juice from frozen concentrate on day 8
Number of subjects: 0
Study 15635354 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial plasma TBARS and vitamin C
Number of subjects: 0
Study 10329338 — intervention group
Group type: COMPARATOR
Intervention: MRRH system (reference group)
Number of subjects: 277
Study 10329338 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 277
Study 8858026 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive injury prevention program
Number of subjects: 0
Study 1928978 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine 72-hour catheter exchange with implantable collagen cuff
Number of subjects: 85
Study 1928978 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine 72-hour catheter exchange without implantable collagen cuff
Number of subjects: 85
Study 1928978 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine 7-day catheter exchange with implantable collagen cuff
Number of subjects: 85
Study 1928978 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine 7-day catheter exchange without implantable collagen cuff
Number of subjects: 85
Study 7117677 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone (1 g at night)
Number of subjects: 25
Study 7117677 — intervention group
Group type: COMPARATOR
Intervention: Naproxen (250 mg b.i.d.)
Number of subjects: 25
Study 29664836 — intervention group
Group type: EXPERIMENTAL
Intervention: Low LY30
Number of subjects: 549
Study 29664836 — intervention group
Group type: COMPARATOR
Intervention: Moderate PAP
Number of subjects: 549
Study 29664836 — intervention group
Group type: COMPARATOR
Intervention: Low PAP
Number of subjects: 549
Study 28877841 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy for health anxiety (CBT-HA) - 4 to 10 sessions of 1-hour CBT-HA
Number of subjects: 444
Study 28877841 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 444
Study 28877841 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy for health anxiety (CBT-HA)
Number of subjects: 444
Study 25343949 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline fibroblast growth factor 23 levels
Number of subjects: 590
Study 25343949 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment for clinical risk factors and baseline eGFR
Number of subjects: 590
Study 24796587 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow eye movement (SEM) analysis during the multiple sleep latency test (MSLT)
Number of subjects: 20
Study 24796587 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow eye movement (SEM) analysis during the maintenance of wakefulness test (MWT)
Number of subjects: 20
Study 24796587 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of SEM latency with sleep latency at MSLT
Number of subjects: 20
Study 24796587 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of SEM latency with sleep latency at MWT
Number of subjects: 20
Study 24796587 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of Epworth Sleepiness Scale score with SEM latency at MSLT
Number of subjects: 20
Study 24796587 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of Epworth Sleepiness Scale score with SEM latency at MWT
Number of subjects: 20
Study 22461443 — intervention group
Group type: EXPERIMENTAL
Intervention: Live High-Train Low (LHTL)
Number of subjects: 16
Study 22461443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 19037576 — intervention group
Group type: EXPERIMENTAL
Intervention: High homocysteine (highest tertile)
Number of subjects: 1213
Study 19037576 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle homocysteine (middle tertile)
Number of subjects: 1213
Study 19037576 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest homocysteine (lowest tertile)
Number of subjects: 1213
Study 19037576 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR genotype variation
Number of subjects: 1213
Study 19037576 — intervention group
Group type: COMPARATOR
Intervention: Homocysteine
Number of subjects: 1213
Study 17917504 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 0
Study 17917504 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan (IRBE) + Quinapril (QUIN)
Number of subjects: 0
Study 15389230 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibrafiban
Number of subjects: 15904
Study 15389230 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 15904
Study 11264066 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal midazolam spray (4 mg)
Number of subjects: 54
Study 11264066 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 54
Study 9681343 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% SDZ ASM 981 cream applied twice daily
Number of subjects: 34
Study 9681343 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% SDZ ASM 981 cream applied once daily
Number of subjects: 34
Study 9681343 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 34
Study 7972616 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute psychological stressor
Number of subjects: 0
Study 7972616 — intervention group
Group type: COMPARATOR
Intervention: Non-stressor control group
Number of subjects: 0
Study 30584532 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum Swing Flexion (MSF)
Number of subjects: 6
Study 30584532 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait Symmetry (GS)
Number of subjects: 6
Study 25758624 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% glucose-containing intravenous solution (D5LR)
Number of subjects: 309
Study 25758624 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's (LR)
Number of subjects: 309
Study 25677670 — intervention group
Group type: EXPERIMENTAL
Intervention: Keratograph 5M
Number of subjects: 30
Study 25677670 — intervention group
Group type: COMPARATOR
Intervention: Fourier-domain optical-coherence tomography (Spectralis OCT)
Number of subjects: 30
Study 25677670 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Keratograph and Spectralis OCT
Number of subjects: 30
Study 23111617 — intervention group
Group type: EXPERIMENTAL
Intervention: Social dinosaur robot
Number of subjects: 24
Study 23111617 — intervention group
Group type: COMPARATOR
Intervention: Human interaction partner
Number of subjects: 24
Study 23111617 — intervention group
Group type: COMPARATOR
Intervention: Touchscreen computer game
Number of subjects: 24
Study 21358360 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid fill
Number of subjects: 92
Study 21358360 — intervention group
Group type: COMPARATOR
Intervention: Air fill
Number of subjects: 92
Study 21358360 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-gauge instrumentation
Number of subjects: 92
Study 21358360 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-gauge instrumentation
Number of subjects: 92
Study 21358360 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of 23-gauge vs 25-gauge
Number of subjects: 92
Study 18430844 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated measurement
Number of subjects: 16
Study 18430844 — intervention group
Group type: COMPARATOR
Intervention: Manual 2D measurement by observer 1
Number of subjects: 16
Study 18430844 — intervention group
Group type: COMPARATOR
Intervention: Manual 3D measurement by observer 1
Number of subjects: 16
Study 18430844 — intervention group
Group type: COMPARATOR
Intervention: Manual 2D measurement by observer 2
Number of subjects: 16